Posted on

Multiple Organ Tissue Array

Please send your request for detailed information and quote to: info@vitrovivo.com

SKU#

DESCRIPTION

CASE

CORE

PRICE ($)

TP241a Top 4 types of cancer (colon, breast, lung and prostate) tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing TP241 12 24 52.00
TP242e Top 4 types of cancer (colon, breast, lung and prostate) with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing TP242d 24 24 84.50
XTP-242e Top 4 types of cancer (colon, breast, lung and prostate) with normal tissue array, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing TP242d 24 24 84.50
TOP481 Top 4 types of cancer (colon, breast, prostate and lung) with normal tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores 24 48 182.00
TOP483 Top 4 types of cancer (colon, breast, prostate and lung) with normal tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores 24 48 214.50
TP481 Top 4 types of cancer (colon, breast, prostate and lung) with normal tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores 48 48 182.00
TP483 Top 4 types of cancer (colon, breast, prostate and lung) with normal tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores 48 48 214.50
TOP482 Top 4 types of cancer (colon, lung, breast and prostate) with normal tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores 48 48 214.50
TMA2081 Colon, prostate and breast tissue array, 156 cases/208 cores 156 208 591.50
GI701 Digestive system (esophagus, stomach, colon, rectum, liver, pancreas) cancer with matched adjacent normal tissue array, including pathology grade, TNM and clinical stage, 35 cases/70 cores 35 70 240.50
GI1441a Digestive system (esophagus, stomach, colon, rectum, liver, pancreas) cancer with matched adjacent normal tissue array, including pathology grade, TNM and clinical stage, 84 cases/144 cores, replacing GI1441 84 144 331.50
MC243a Multiple cancer (3 types) tissue array, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing MC243 24 24 117.00
BCN721 Multiple cancer tissue array with cancer adjacent tissue, including pathology grade 71 72 292.50
BCN721a Multiple cancer tissue array with cancer adjacent tissue, including pathology grade, TNM and clinical stage, replaing BCN721 72 72 292.50
MC808 Multiple cancer tissue array, including TNM and clinical stage, 40 cases/80 cores 40 80 331.50
CYFDA1f FDA multiple organ normal tissue array of cynomolgus monkey, 20 cases/99 cores, replacing CyFDA1e 32 99 331.50
GI801 GI (oral cavity, esophagus, stomach, small intestine, pancreas, liver, gall bladder, appendix, colon, rectum) Stage IV cancer tissue array, including pathology grade, TNM and clinical stage, 80 cases/ 80 cores 80 80 383.50
TMA2401a High density multiple organ (top 4) cancer tissue array (240 cores), including TNM, clinical stage, pathology grade and gleason grade, 220 cases/240 cores, replacing TMA2401 240 240 591.50
TOP4-240a High density multiple organ (top 4) cancer tissue array (240 cores), including TNM, clinical stage, pathology grade and gleason grade, 220 cases/240 cores, replacing TMA2401 220 240 591.50
BM01011 Mouse multiple organ normal tissue array, 160 cases/160 cores, replaced by MO1601 160 160 292.50
MO1601a Mouse multiple organ normal tissue array, 160 cases/160 cores, replacing MO1601 160 160 292.50
BN242c Multiple normal (12 type) tissue array, 12 cases/24 cores, replaced BN242a 12 24 71.50
BN243c Multiple normal (12 type) tissue array, 12 cases/24 cores, replaced BN243a 12 24 71.50
BN114a Multiple normal human organ tissue array, 48 cases/48 cores, replacing BN114 48 48 182.00
BN114b Multiple normal human organ tissue array, 48 cases/48 cores, replacing BN114a 48 48 182.00
MNC151 Multiple normal organ tissue array, 15 cases/15 cores 15 15 84.50
MC641 Multiple organ cancer and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 59 cases/64 cores, replacing BC00115 59 64 331.50
T004 Multiple organ cancer and normal tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 71.50
T005 Multiple organ cancer and normal tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 71.50
T006 Multiple organ cancer and normal tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 71.50
T003 Multiple organ cancer and normal tissue array, including TNM and pathology grade, 6 cases/24 cores 6 24 71.50
T0011 Multiple organ cancer and normal tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 71.50
T0013 Multiple organ cancer and normal tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 71.50
T011a Multiple organ cancer and normal tissue test array, including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 52.00
T0010 Multiple organ cancer test tissue array with normal tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 71.50
T008 Multiple organ cancer test tissue array with normal tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 71.50
T007 Multiple organ cancer test tissue array, with normal tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores 6 24 71.50
FDA808i-2 Multiple organ cancer tissue array with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FDA808h-2 72 72 331.50
MC543a Multiple organ cancer tissue array, including TNM and pathology grade, 54 cases/ 54 cores, replacing MC543 54 54 383.50
BCN601 Multiple organ cancer with normal tissue array, including pathology grade, TNM and clinical stage, 60 cases/60 cores 60 60 292.50
T0012 Multiple organ cancer with normal tissue test array, including pathology grade, TNM and clinical satge, 6 cases/24 cores 6 24 71.50
T012a Multiple organ cancer with normal tissue test array, including pathology grade, TNM and clinical satge, 6 cases/24 cores 6 24 45.50
MET-961b Multiple organ metastatic carcinoma tissue array, including pathology grade, 48 cases/96 cores, replacing MET961a 48 96 331.50
MC811 Multiple organ normal tissue and cancer tissue array, including pathology grade, TNM and clinical stage, 75 cases/81 cores 75 81 331.50
MC911 Multiple organ normal tissue and cancer tissue array, including pathology grade, TNM and clinical stage, 83 cases/88 cores 83 88 383.50
BN119 Multiple organ normal tissue array, 19 cases/19 cores 19 19 71.50
BN481 Multiple organ normal tissue array, 24 cases/48 cores 24 48 383.50
BN129 Multiple organ normal tissue array, 34 cases/48 cores, replacing BN116 34 48 182.00
MBN481a Multiple organ normal tissue array, 35 cases/48 cores, replacing MBN481 48 48 253.50
BN00119 Multiple organ normal tissue array, 40 cases/40 cores, replacing BN00112 40 40 292.50
BN501b Multiple organ normal tissue array, 43 cases/50 cores, replacing BN501a 43 50 182.00
BN117a Multiple organ normal tissue array, 45 cases/45 cores, replacing BN117 45 45 182.00
BN115a Multiple organ normal tissue array, 46 cases/46 cores, replacing BN115 46 46 182.00
FDA808h-1 Multiple organ normal tissue array, 56 cases/72 cores, replacing FDA808g-1 72 72 331.50
FDA901 Multiple organ tissue array, 67 cases/90 cores 30 90 331.50
FDA999r Multiple organ tissue array, 70 cases/ 99 cores, replacing FDA999q 70 99 331.50
FDA990 Multiple organ tissue array, 75 cases/99 cores, replacing FDA999z 99 99 331.50
MCN602a Multiple organ tumor and cancer adjacent normal tissue array, including pathology grade, TNM and clinical stage, 60 cases/60 cores, replacing MCN602a 60 60 292.50
MC601 Multiple organ tumor and metastatic carcinoma tissue array, including pathology grade, TNM and clinical stage, 60 cases/60 cores 60 60 331.50
MC803a Multiple organ tumor tissue array with adjacent normal tissue, including TNM and clinical stage, 40 cases/80 cores, replacing MC803 40 80 364.00
FDA808Ci-2 Multiple organ tumor tissue array with cancer adjacent normal tissue, including pathology grade, TNM and clinical stage, 72 cases/72 cores 72 72 331.50
MC2082d Multiple organ tumor tissue array, including pathology grade, TNM and clinical stage, 192 cases/192 cores, replacing MC2082c 192 192 591.50
MC485 Multiple organ tumor tissue array, including pathology grade, TNM and clinical stage, 24 cases/48 cores 24 48 240.50
FDA800c Multiple organ tumor tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FDA800b 72 72 331.50
FDA800d Multiple organ tumor tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FDA800c 80 80 331.50
MC964a Multiple organ tumor tissue array, including pathology grade, TNM and clinical stage, 96 cases/96 cores, replacing MC964 96 96 331.50
MC246c Multiple organ tumor with matched adjacent normal or cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing MC246b 12 24 71.50
MC246d Multiple organ tumor with matched adjacent normal or cancer adjacent tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing MC246c 12 24 71.50
MC963 Multiple organ tumor with normal tissue array, including pathology grade, TNM and clinical stage, 13 cases/96 cores 13 96 331.50
FDA808h-2 Multiple organ tumor with normal tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FDA808g-2 72 72 331.50
MC2081b Multiple organ tumor with normal tissue array, including pathology grade, TNM, clinical stage, Gleason grade and Gleason score, 208 cases/208 cores, replacing MC2081a 208 208 591.50
COM501 Multiple organ tumor with normal tissue array, including TNM and clinical stage, 48 cases/48 cores 48 48 221.00
NOR481 Multiple organs normal tissue array, 24 cases/48 cores 24 48 221.00
LN802b Multiple organs normal tissue array, including lymph node, thymus gland, spleen, tonsil and appendix, 80 cases/80 cores, replacing LN802a 80 80 292.50
CM241 Multiple organs tumor tissue array with normal tissue, ,12 cases/24 cores 24 24 71.50
BCN482 Multiple organs tumor tissue array with normal tissue, 48 cases/48 cores 48 48 292.50
MC1801a Multiple organs tumor tissue array, including pathology grade, TNM and clinical stage, 180 cases/180 cores, replacing MC1801 180 180 377.00
BR20838 Multiple organs tumor tissue array, including pathology grade, TNM, clinical stage IHC markers (ER, PR, Her-2) results, 118 cases/208 cores 118 208 513.50
MC616 High-density lung, breast, brain, colon cancer array, including pathology grade, TNM and clinical stage, 308 cases/616 cores 308 616 1033.50
MC5003c High-density multiple organs tumor with normal tissue array, including pathology grade, TNM and clinical stage, 500 cases/500 cores, replacing MC5003b 500 500 890.50
MC5003d High-density multiple organs tumor with normal tissue array, including pathology grade, TNM and clinical stage, 500 cases/500 cores, replacing MC5003c 500 500 890.50
MC1081a Immune multiple organs tumor and normal tissue array, 108 cases/108 cores, replacing MC1081 108 108 448.50
BC01071a Multiple organ cancer tissue array, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BC01071 48 48 182.00
BC001157 Multiple organ tumor tissue array with normal tissue, including pathology grade, TNM and clinical stage, 72 cases/72 cores 72 72 292.50
BC001134a Multiple organs tumor and normal tissue array, including pathology grade, TNM and clinical stage, 150 cases/150 cores, replacing BC001134 150 150 513.50
BC00116 Multiple organs tumor tissue array with adjacent normal tissue, including pathology grade, TNM and clinical stage, 44 cases/48 cores 44 48 292.50
GI481 GI (stomach, colon, rectum) tumor tissue array with adjacent normal tissue, including pathology grade, 24 cases/48 cores 24 48 149.50
MC6162 High-density stomach, colon, rectum cancer and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 616 cases/616 cores 616 616 1033.50

TMA Applications:

Routine histology procedures including immunohistochemistry (IHC) and in situ hybridization (ISH)

Notes:

1) TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.

TNM Grading

T – Primary tumor
      Tx – Primary tumor cannot be assessed
      T0 – No evidence of primary tumor
      Tis – Carcinoma in situ; intraepithelial or invasion of lamina propria
      T1 – Tumor invades submucosa
      T2 – Tumor invades muscularis propria
      T3 – Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
      T4 – Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N – Regional lymph nodes
     Nx – Regional lymph nodes cannot be assessed
     N0 – No regional lymph node metastasis
     N1 – Metastasis in 1 to 3 regional lymph nodes
     N2 – Metastasis in 4 or more regional lymph nodes

M – Distant metastasis
     Mx – Distant metastasis cannot be assessed
     M0 – No distant metastasis
     M1 – Distant metastasis

Stage of Cancer

  • Stage 0 means there’s no cancer, only abnormal cells with the potential to become cancer. This is also called carcinoma in situ.
  • Stage I means the cancer is small and only in one area. This is also called early-stage cancer.
  • Stage II and III mean the cancer is larger and has grown into nearby tissues or lymph nodes.
  • Stage IV means the cancer has spread to other parts of your body. It’s also called advanced or metastatic cancer.